At annual leadership meeting, HDMA bestows Nexus and DIANA awards
David Moody of Mutual Wholesale Drug Co. wins individual recognition; Depomed and Forest Pharmaceuticals the manufacturer awards
At its annual HDMA Business and Leadership Conference (Phoenix, June 1-4), the Healthcare Distribution Management Assn. presented its Nexus Award, for individual lifetime achievement, and the Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) Awards. The Nexus winner is David Moody, RPh, CEO of Mutual Wholesale Drug Co. (Durham, NC), who began working in a local pharmacy during high school, and eventually rose to CEO of Mutual. He has been the chairman of the HDMA board in recent years.
The DIANA Awards recognize overall manufacturer excellence in supply chain innovation, and trade relations; awards are also bestowed for new product introductions, and for “manufacturer partner of the year" for manufacturers supporting HDMA activities. The DIANA Awards for overall excellence went to Depomed, Inc. (sales under $50 million) and Forest Pharmaceuticals (sales over $50 million). Best product introductions were Eisai, for Belviq (lorcaserin) and Citron Pharma for duloxetine (generic). The award for a manufacturer-partners went to Mylan, Inc. (>$50 million) and Upsher-Smith Laboratories (<$50 million).
Becton Dickinson was also recognized at the meeting with the AmeriCares Power of Partnership Award; AmeriCares is the global health and disaster-relief non-profit.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
